Browse by Person

Up a level
Export as [feed] RSS 2.0 [feed] RSS 1.0 [feed] Atom
Group by: Item Type | Date | No Grouping
Number of items: 90.

Osman, R., Kan, P.L., Awad, G., Mortada, N., EL-Shamy, A-E. and Alpar, H.O. (2011) Enhanced properties of discrete pulmonary deoxyribonuclease I (DNaseI) loaded PLGA nanoparticles during encapsulation and activity determination. International Journal of Pharmaceutics, 408 (1-2). pp. 257-265. 10.1016/j.ijpharm.2011.02.013.

Florindo, H., Pandit, S., Goncalves, I., Alpar, H.O. and Almeida, A.J. (2010) Surface modified polymeric nanoparticles for immunisation against equine strangles. International Journal of Pharmaceutics, 390 (1). pp. 25-31. 10.1016/j.ijpharm.2009.10.009 .

Wang, Y., Lam, J., Zhang, B., Tomlins, P.E., Li, X., Alpar, H.O., Wertheim, D.F., Jones, A.S. and Coombes, A.G.A. (2010) Biomechanical Characterization of a Micro/Macroporous Polycaprolactone Tissue Integrating Vascular Graft. Cardiovascular Engineering and Technology, 1 (3). pp. 202-215. doi:10.1007/s13239-010-0019-1.

Uchida, M., Li, X., Mertens, P. and Alpar, H.O. (2009) Transfection by particle bombardment: delivery of plasmid DNA into mammalian cells using gene gun. Biochimica et Biophysica Acta, 1790 (8). pp. 754-764. 10.1016/j.bbagen.2009.05.013.

Dahlan, A., Alpar, H.O. and Murdan, S. (2009) An investigation into the combination of low frequency ultrasound and liposomes on skin permeability. International Journal of Pharmaceutics, 379 (1). pp. 139-142. doi:10.1016/j.ijpharm.2009.06.011.

Wang, Y., Chang, H-I., Li, X., Alpar, H.O. and Coombes, A. (2009) Delivery of bioactive macromolecules from microporous polymer matrices: release and activity profiles of lysozyme, collagenase and catalase. European Journal of Pharmaceutical Sciences, 37 . pp. 387-394. 10.1016/j.ejps.2009.03.010.

Kaye, R.S., Purewal, T.S. and Alpar, H.O. (2009) Development and testing of particulate formulations for the nasal delivery of antibodies. Journal of Controlled Release, 135 (2). pp. 127-135. doi:10.1016/j.jconrel.2008.11.009.

Tse, M.T., Blatchford, C. and Alpar, H.O. (2009) Evaluation of different buffers on plasmid DNA encapsulation into PLGA microparticles. International Journal of Pharmaceutics, 370 (1-2). pp. 33-40. doi:10.1016/j.ijpharm.2008.11.006.

Florindo, H., Pandit, S., Goncalves, L., Alpar, H.O. and Almeida, A.J. (2009) New approach on the development of a mucosal vaccine against strangles: Systemic and mucosal immune responses in a mouse model. Vaccine, 27 (8). pp. 1230-1241. 10.1016/j.vaccine.2008.12.004.

Katas, H., Cevher, E. and Alpar, H.O. (2009) Preparation of polyethyleneimine incorporated poly(d,l-lactide-co-glycolide) nanoparticles by spontaneous emulsion diffusion method for small interfering RNA delivery. International Journal of Pharmaceutics, 369 (1-2). pp. 144-154. doi:10.1016/j.ijpharm.2008.10.012.

Kaye, R.S., Purewal, T.S. and Alpar, H.O. (2009) Simultaneously manufactured nano-in-micro (SIMANIM) particles for dry-powder modified-release delivery of antibodies. Journal of Pharmaceutical Sciences, 98 (11). pp. 4055-4068. doi:10.1002/jps.21673.

Kaye, R.S., Purewal, T.S. and Alpar, H.O. (2009) Simultaneously manufactured nano-in-micro (SIMANIM) particles for dry-powder modified-release delivery of antibodies. Journal of Pharmaceutical Sciences, 98 (11). pp. 4055-4068. 10.1002/jps.21673.

Florindo, H.F., Pandit, S., Lacerda, L., Gonçalves, L.M.D., Alpar, H.O. and Almeida, A.J. (2009) The enhancement of the immune response against S. equi antigens through the intranasal administration of poly-ɛ-caprolactone-based nanoparticles. Biomaterials, 30 (5). pp. 879-891. 10.1016/j.biomaterials.2008.10.035.

Sayin, B., Somavarapu, S., Li, X.W., Sesardic, D., Senel, S. and Alpar, H.O. (2009) TMC-MCC (N-trimethyl chitosan-mono-N-carboxymethyl chitosan) nanocomplexes for mucosal delivery of vaccines. European Journal of Pharmaceutical Sciences, 38 (4). pp. 362-369. 10.1016/j.ejps.2009.08.010.

Dahlan, A., Alpar, H.O., Stickings, P., Sesardic, D. and Murdan, S. (2009) Transcutaneous immunisation assisted by low-frequency ultrasound. International Journal of Pharmaceutics, 368 (1-2). pp. 123-128. doi:10.1016/j.ijpharm.2008.10.014.

Katas, H., Chen, S., Osamuyimen, A.A., Cevher, E. and Alpar, H.O. (2008) Effect of preparative variables on small interfering RNA loaded Poly(D,L-lactide-co-glycolide)-chitosan submicron particles prepared by emulsification diffusion method. Journal of Microencapsulation, 25 (8). pp. 541-548. doi:10.1080/02652040802075567.

Sayın, B., Somavarapu, S., Li, X.W., Thanou, M., Sesardic, D., Alpar, H.O. and Şenel, S. (2008) Mono-N-carboxymethyl chitosan (MCC) and N-trimethyl chitosan (TMC) nanoparticles for non-invasive vaccine delivery. International Journal of Pharmaceutics, 363 (1-2). pp. 139-148. 10.1016/j.ijpharm.2008.06.029.

Colonna, C., Conti, B., Genta, I. and Alpar, H.O. (2008) Non-viral dried powders for respiratory gene delivery prepared by cationic and chitosan loaded liposomes. International Journal of Pharmaceutics, 364 (1). pp. 108-118. 10.1016/j.ijpharm.2008.07.034.

Florindo, H., Pandit, S., Goncalves, L., Alpar, H.O. and Almeida, A.J. (2008) Streptococcus equi antigens adsorbed onto surface modified poly-ɛ-caprolactone microspheres induce humoral and cellular specific immune responses. Vaccine, 26 (33). pp. 4168-4177. 10.1016/j.vaccine.2008.05.074.

Shaw, A., Monaghan, P., Alpar, H.O., Anthony, S., Darpel, K., Batten, C., Guercio, A., Alimena, G., Vitale, M. and Bankowska, K. (2007) Development and initial evaluation of a real-time RT-PCR assay to detect bluetongue virus genome segment 1☆. Journal of Virological Methods, 145 (2). pp. 115-126. 10.1016/j.jviromet.2007.05.014.

Pandit, S., Cevher, E., Zariwala, M.G., Somavarapu, S. and Alpar, H.O. (2007) Enhancement of immune response of HBsAg loaded poly (L-lactic acid) microspheres against Hepatitis B through incorporation of alum and chitosan. Journal of Microencapsulation, 24 (6). pp. 539-552. doi:10.1080/02652040701443700.

Katas, H. and Alpar, H.O. (2006) Development and characterisation of chitosan nanoparticles for siRNA delivery. Journal of Controlled Release, 115 (2). pp. 216-225. 10.1016/j.jconrel.2006.07.021.

Dahlan, A., Alpar, H.O. and Murdan, S. (2006) A study into the application of ultrasound and liposome combination on skin permeability. In: British Pharmaceutical Conference, 2006.

Dahlan, A., Alpar, H.O. and Murdan, S. (2006) A study into the application of ultrasound and liposome combination on skin permeability. Journal of Pharmacy and Pharmacology, 58 . A46-A46.

Singh, J., Pandit, S., Bramwell, V.W. and Alpar, H.O. (2006) Diptheria toxoid loaded poly-(epsilon-caprolactone) nanoparticles as mucosal vaccine delivery systems. Methods, 38 (2). pp. 96-105. 10.1016/j.ymeth.2005.11.003 .

Dahlan, A., Alpar, H.O. and Murdan, S. (2006) Effect of SDS concentration in the coupling medium on ultrasound-induced changes in skin barrier. In: British Pharmaceutical Conference, 2006.

Dahlan, A., Alpar, H.O. and Murdan, S. (2006) Effect of SDS concentration in the coupling medium on ultrasound-induced changes in skin barrier. Journal of Pharmacy and Pharmacology, 58 (Suppl. 1). A45-A46.

Moschos, S.A., Bramwell, V.W., Somavarapu, S. and Alpar, H.O. (2006) Modulating the adjuvanticity of alum by co-administration of muramyl di-peptide (MDP) or Quil-A. Vaccine, 24 (8). pp. 1081-1086. 10.1016/j.vaccine.2005.09.007.

Dahlan, A., Alpar, H.O. and Murdan, S. (2006) Needle-free skin immunization using low frequency ultrasound. Journal of Pharmacy and Pharmacology, 58 . A45-A45.

Dahlan, A., Alpar, H.O. and Murdan, S. (2006) Needle-free skin immunization using low-frequency ultrasound. In: British Pharmaceutical Conference, 2006.

Elvin, S.J., Eyles, J.E., Howard, K.A., Ravichandran, E., Somavarapu, S., Alpar, H.O. and Williamson, E.D. (2006) Protection against bubonic and pneumonic plague with a single dose microencapsulated sub-unit vaccine. Vaccine, 24 . pp. 4433-4439. 10.1016/j.vaccine.2005.12.016.

Dahlan, A., Alpar, H.O. and Murdan, S. (2006) Skin immunization using ultrasound: potential of low sodium dodecyl sulphate concentration for producing synergistic effects. In: AAPS Annual Meeting, 29th October - 2nd November 2006, San Antonio, Texas, USA.

Bridson, R.H., Santos, R.C.D., Al-Duri, B., McAllister, S.M., Robertson, J. and Alpar, H.O. (2006) The preparation of liposomes using compressed carbon dioxide: strategies, important considerations and comparison with conventional techniques. Journal of Pharmacy and Pharmacology, 58 (6). pp. 775-785. 10.1211/jpp.58.6.0008.

Dahlan, A., Alpar, H.O. and Murdan, S. (2005) Abstract: An investigation into protein stability following low-frequency ultrasound application. In: British Pharmaceutical Conference, 2005. DOI 10.1211/002235705778248352.

Dahlan, A., Alpar, H.O. and Murdan, S. (2005) Abstract: An investigation into protein stability following low-frequency ultrasound application. Journal of Pharmacy and Pharmacology, 57 . 10.1211/002235705778248352.

Dahlan, A., Alpar, H.O. and Murdan, S. (2005) Abstract: Effect of coupling medium volume on sonophoresis of proteins. In: British Pharmaceutical Conference, 2005. DOI 10.1211/002235705778248479.

Dahlan, A., Alpar, H.O. and Murdan, S. (2005) Abstract: Effect of coupling medium volume on sonophoresis of proteins through rat skin. Journal of Pharmacy and Pharmacology, 57 . S51-S51.

Dahlan, A., Alpar, H.O. and Murdan, S. (2005) Abstract: Effect of probe distance on sonophoresis of proteins through rat skin. Journal of Pharmacy and Pharmacology, 57 . S51-S51.

Dahlan, A., Alpar, H.O. and Murdan, S. (2005) Abstract: Effect of surfactant concentration on sonophoresis of proteins through rat skin. In: British Pharmaceutical Conference, 2005. DOI 10.1211/002235705778248479.

Dahlan, A., Alpar, H.O. and Murdan, S. (2005) Abstract: Effect of surfactant concentration on sonophoresis of proteins through rat skin. Journal of Pharmacy and Pharmacology, 57 (Supp S). S51-S52.

Alpar, H.O., Somavarapu, S., Atuah, K.N. and Bramwell, V.W. (2005) Biodegradable mucoadhesive particulates for nasal and pulmonary antigen and DNA delivery. Advanced Drug Delivery Reviews, 57 (3). pp. 411-430. 10.1016/j.addr.2004.09.004.

Pollitt, M.J., Buckton, G., Brocchini, S. and Alpar, H.O. (2005) Calorimetric study of bovine serum albumin dilution and adsorption onto polystyrene particles. International Journal of Pharmaceutics, 298 (2). pp. 339-343. 10.1016/j.ijpharm.2005.02.037.

Martin, C., Thongborisute, J., Takeuchi, H., Yamamoto, H., Kawashima, Y. and Alpar, H.O. (2005) Cholesterol-bile salt vesicles as potential delivery vehicles for drug and vaccine delivery. International Journal of Pharmaceutics, 298 (2). pp. 339-343. 10.1016/j.ijpharm.2005.03.038 .

Moschos, S.A., Bramwell, V.W., Somavarapu, S. and Alpar, H.O. (2005) Comparative immunomodulatory properties of a chitosan-MDP adjuvant combination following intranasal or intramuscular immunisation. Vaccine, 23 (16). pp. 1923-1930. 10.1016/j.vaccine.2004.10.016 .

Dahlan, A., Alpar, H.O. and Murdan, S. (2005) Effect of probe distance on sonophoresis of proteins through rat skin. In: British Pharmaceutical Conference, 2005.

Somavarapu, S., Pandit, S., Gradassi, G., Bandera, M., Ravichandran, E. and Alpar, H.O. (2005) Effect of Vitamin E TPGS on immune response to nasally delivered diphtheria toxoid load poly(caprolactone) microparticles. International Journal of Pharmaceutics, 298 (2). pp. 344-347. 10.1016/j.ijpharm.2005.03.029 .

Murdan, S., Somavarapu, S., Ross, A.C., Alpar, H.O. and Parker, M.C. (2005) Immobilisation of vaccines onto micro-crystals for enhanced thermal stability. International Journal of Pharmaceutics, 296 (1-2). pp. 117-121. 10.1016/j.ijpharm.2005.02.022 .

Papanicolaou, I., Briggs, B. and Alpar, H.O. (2005) Increased resistance of DNA lipoplexes to protein binding in vitro by surface-modification with a multivalent hydrophilic polymer. Journal of Drug Targeting, 12 (8). pp. 541-547. 10.1080/10611860400011950.

Hansen, R.K., Zhai, S., Skepper, J.N., Johnston, M.D., Alpar, H.O. and Slater, N.K.H. (2005) Mechanisms of inactivation of HSV-2 during storage in frozen and lyophilised forms. Biotechnology Progress, 21 (3). pp. 911-917. 10.1021/bp049601a.

Martin, C., Somavarapu, S. and Alpar, H.O. (2005) Mucosal delivery of diptheria toxoid using polymer-coated-bioadhesive liposomes as vaccine carriers. Journal of Drug Delivery Science and Technology, 15 (4). pp. 301-306.

Alpar, H.O. and Brey, R.N. (2005) New frontiers in vaccines for emerging pathogens. Advanced Drug Delivery Reviews, 57 (9). pp. 1243-1246. 10.1016/j.addr.2005.01.029.

Dahlan, A., Alpar, H.O. and Murdan, S. (2005) Optimisation of low-frequency ultrasound parameters for transcutaneous protein delivery. Journal of Pharmacy and Pharmacology, 57 . S50-S51.

Bramwell, V.W., Eyles, J.E. and Alpar, H.O. (2005) Particulate delivery systems for biodefense subunit vaccines. Advanced Drug Delivery Reviews, 57 (3). pp. 1247-1265. 10.1016/j.addr.2004.09.009.

Pandit, S., Martin, C. and Alpar, H.O. (2005) Positively charged rifampicin-loaded microspheres for lung delivery. Journal of Drug Delivery Science and Technology, 15 (4). pp. 281-287.

Alpar, H.O., Papanicolaou, I. and Bramwell, V.W. (2005) Strategies for DNA vaccine delivery. Expert Opinion on Drug Delivery, 2 (5). pp. 829-842. 10.1517/17425247.2.5.829.

Moschos, S.A., Bramwell, V.W., Somavarapu, S. and Alpar, H.O. (2004) Adjuvant synergy: the effects of nasal coadministration of adjuvants. Immunology and Cell Biology, 82 (6). pp. 628-637. 10.1111/j.0818-9641.2004.01280.x.

Kusonwiriyawong, C., Atuah, K.N., Alpar, H.O., Merkle, H.P. and Walter, E. (2004) Cationic stearylamine-containing biodegradable microparticles for DNA delivery. Journal of Microencapsulation, 21 (1). pp. 25-36. 10.1080/02652040410001653777.

Howard, K.A., Li, X., Somavarapu, S., Singh, J., Green, N., Atuah, K.N., Ozsoy, Y., Seymour, L.W. and Alpar, H.O. (2004) Formulation of microparticle carrier for oral polyplex-based DNA vaccines. Biochimica et Biophysica Acta, 1674 (2). pp. 149-157. 10.1016/j.bbagen.2004.06.009.

Eyles, J.E., Elvin, S.J., Westwood, A., Lebutt, C.S. and Alpar, H.O. (2004) Immunisation against plague by transcutaneous and intradermal application of subunit antigens. Vaccine, 22 (31-32). 4365 -4373. 10.1016/j.vaccine.2004.02.049.

Eyles, J.E., Elvin, S.J., Westwood, A., Lebutt, C.S., Alpar, H.O., Somavarapu, S. and Williamson, E.D. (2004) Immunisation against plague by transcutaneous and intradermal application of subunit antigens. Vaccine, 22 (31-32). p. 4365. 10.1016/j.vaccine.2004.02.049.

Kohli, A.K. and Alpar, H.O. (2004) Potential use of nanoparticles for transcutaneous vaccine delivery: effect of particle size and charge. International Journal of Pharmaceutics, 275 (1-2). pp. 13-17. 10.1016/j.ijpharm.2003.10.038 .

Eyles, J.E., Bramwell, V.W., Singh, J., Williamson, E.D. and Alpar, H.O. (2003) Stimulation of spleen cells in vitro by nanospheric particles containing antigen. Journal of Controlled Release, 86 (1). pp. 25-32. 10.1016/S0168-3659(02)00296-1 .

Bramwell, V.W., Somavarapu, S., Outschoorn, I. and Alpar, H.O. (2003) Adjuvant action of melittin following intranasal immunisation with tetanus and diphtheria toxoids. Journal of Drug Targeting, 11 (8-10). pp. 525-530. 10.1080/10611860410001683013.

Atuah, K.N., Walter, E., Merkle, H.P. and Alpar, H.O. (2003) Encapsulation of plasmid DNA in PLGA-stearylamine microspheres: a comparison of solvent evaporation and spray-drying methods. Journal of Microencapsulation, 20 (3). pp. 387-399. 10.1080/10611860410001683013.

Eyles, J.E., Carpenter, Z.C., Alpar, H.O. and Williamson, E.D. (2003) Immunological aspects fo polymer microsphere vaccine delivery systems. Journal of Drug Targeting, 11 . pp. 509-514. 10.1080/10611860410001670017.

Somavarapu, S., Bramwell, V.W. and Alpar, H.O. (2003) Oral plasmid DNA delivery systems for genetic immunisation. Journal of Drug Targeting, 11 (8-10). pp. 547-553. 10.1080/10611860410001683022.

Alpar, H.O., Murdan, S., Outschoorn, I., Bramwell, V.W. and Somavarapu, S. (2003) Quil-A - Chitosan: A novel mucosal adjuvant. In: MVADS Conference, 4-6 June 2003, Dublin, Republic of Ireland.

Alpar, H.O. (2003) Strategies for vaccine delivery. Journal of Drug Targeting, 11 (8-10). pp. 459-461. 10.1080/10611860410001683013.

Li, X., Lee, D.K., Chan, A.S. and Alpar, H.O. (2003) Sustained expression in mammalian cells with DNA complexed with chitosan nanoparticles. Biochimica et Biophysica Acta, 1630 (1). pp. 387-399.

Murdan, S., Ross, A.C., Parker, M.C., Alpar, H.O. and Somavarapu, S. (2003) Vaccine-coated microcrystals: Enhanced thermal stability of diphtheria taxoid. Journal of Pharmacy and Pharmacology, 55 (Supplement). S.71-S.72.

Murdan, S., Ross, A.C., Parker, M.C., Alpar, H.O. and Somavarapu, S. (2003) Vaccine-coated microcrystals: enhanced thermal stability of diphtheria toxoid. In: British Pharmaceutical Conference, 2003.

Bramwell, V.W., Eyles, J.E., Somavarapu, S. and Alpar, H.O. (2002) Liposome/DNA complexes coated with biodegradable PLA improve immune responses to plasmid encoding hepatitis B surface antigen. Immunology, 106 (3). pp. 412-418. 10.1046/j.1365-2567.2002.01448.x.

Flick-Smith, H.C., Eyles, J.E., Hebdon, R., Waters, E.L., Beedham, R.J., Stagg, T.J., Miller, J., Alpar, H.O., Baillie, L.W.J. and Williamson, E.D. (2002) Mucosal or parenteral administration of microsphere-associated Bacillus anthracis protective antigen protects against anthrax infection in mice. Infection and Immunity, 70 (4). pp. 2022-2028. 10.1128/IAI.70.4.2022-2028.2002.

Alpar, H.O. and Bramwell, V.W. (2002) Current status of DNA vaccines and their route of administration. Critical Reviews in Therapeutic Drug Carrier Systems, 19 (4-5). pp. 307-383. 10.1615/CritRevTherDrugCarrierSyst.v19.i45.

Griffin, K.F., Eyles, J.E., Spiers, I.D., Alpar, H.O. and Williamson, E.D. (2002) Protection against plague following immunisation with microencapsulated V antigen is reduced by co-encapsulation with IFN-gamma or IL-4, but not IL-6. Vaccine, 20 (31-32). pp. 3650-3657. 10.1016/S0264-410X(02)00396-1.

Howard, K.A. and Alpar, H.O. (2002) The development of polyplex-based DNA vaccines. Journal of Drug Targeting, 10 (2). pp. 143-151.

Alpar, H.O., Eyles, J.E., Williamson, E.D. and Somavarapu, S. (2001) Intranasal vaccination against plague, tetanus and diphtheria. Advanced Drug Delivery Reviews, 51 (1-3). pp. 173-201. 10.1016/S0169-409X(01)00166-1 .

Eyles, J.E., Bramwell, V.W., Williamson, E.D. and Alpar, H.O. (2001) Microsphere translocation and immunopotentiation in systemic tissues following intranasal administration. Vaccine, 19 (32). pp. 4732-4742. 10.1016/S0264-410X(01)00220-1.

Eyles, J.E., Spiers, I.D., Williamson, E.D. and Alpar, H.O. (2001) Tissue distribution of radioactivity following intranasal administration of radioactive microspheres. Journal of Pharmacy and Pharmacology, 53 (5). pp. 601-607. 10.1211/0022357011775929.

Eyles, J.E., Williamson, E.D., Spiers, I.D., Stagg, A.J., Jones, S.M. and Alpar, H.O. (2000) Generation of protective immune responses to plague by mucosal administration of microsphere coencapsulated recombinant subunits. Journal of Controlled Release, 63 (1-2). pp. 191-200. 10.1016/S0168-3659(99)00197-2.

Ward, K, Adams, G.D.J, Alpar, H.O. and Irwin, W. (1999) Protection of the enzyme ?-asparaginase during lyophilisation—a molecular modelling approach to predict required level of lyoprotectant. International Journal of Pharmaceutics, 187 (2). pp. 153-162. 10.1016/S0378-5173(99)00163-5.

Griffin, K.F., Conway, B.R., Alpar, H.O. and Williamson, E.D. (1998) Immune responses to V antigen of Yersinia pestis co-encapsulated with IFN-$gamma;: effect of dose and formulation. Vaccine, 16 (5). pp. 517-521.

Conway, B., Eyles , J.E. and Alpar, H.O. (1997) A comparative study on the immune responses to antigens in PLA and PHB microspheres. Journal of Controlled Release, 49 (1). pp. 1-9. 10.1016/S0168-3659(97)01641-6.

McAllister, S.M., Alpar, H.O., Teitelbaum, Z. and Bennett, D.B. (1996) Do interactions with phospholipids contribute to the prolonged retention of polypeptides within the lung? Advanced Drug Delivery Reviews, 19 (1). pp. 89-110. 10.1016/0169-409X(95)00101-C.

Ward, K., Alpar, H.O., Adams, G., Atuah, K.N. and Irwin, W. (1996) Effects of lyophilisation on the formation and stability of stealth liposomes. European Journal of Pharmaceutical Sciences, 4 (Supp 1). S173. 10.1016/S0928-0987(97)86522-0.

Poyner, E., Alpar, H.O., Almeida, A.J., Gamble, M.D. and Brown, M.R.W. (1995) A comparative study on the pulmonary delivery of tobramycin encapsulated into liposomes and PLA microspheres following intravenous and endotracheal delivery. Journal of Controlled Release, 35 (1). pp. 41-48. 10.1016/0168-3659(95)00017-3.

Almeida, A.J. and Alpar, H.O. (1994) P281 microsphere adjuvanticity: Influence of polymer, dose and size on the humoral response to microencapsulated tetanus toxoid. European Journal of Pharmaceutical Sciences, 2 (1-2). p. 189.

Alpar, H.O., Bowen, J. and Brown, M.R.W. (1992) Effectiveness of liposomes as adjuvants of orally and nasally administered tetanus toxoid. International Journal of Pharmaceutics, 88 (1-3). pp. 335-344. 10.1016/0378-5173(92)90332-V.

Bowen, J., Alpar, H.O., Phillpotts, R. and Brown, M.R.W. (1992) Mucosal delivery of herpes simplex virus vaccine. Research in Virology, 143 . pp. 269-278. 10.1016/S0923-2516(06)80115-9.

Alpar, H.O., Bason, A., Hickman, J., Richards, F. and Field, W. (1990) Estimation by FACS of the delivery of liposome encapsulated macromolecules into myeloid cells. International Journal of Pharmaceutics, 62 (2-3). pp. 133-141. 10.1016/0378-5173(90)90227-U.

This list was generated on Sat Oct 25 15:44:36 2014 BST.